Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 9868-9877

  Bieniasz, P D ^a   Cullen, B R ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY DNA; GAG PROTEIN; GENE PRODUCT; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; VIRION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

ANIMAL; ANTIGENS, CD4; CELL FUSION; CELL LINE; CHO CELLS; CYCLINS; GENE PRODUCTS, GAG; HAMSTERS; HIV-1; HUMAN; MICE; RATS; RECEPTORS, HIV; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0033779574     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.9868-9877.2000     Document Type: Article

References (47)

1. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells
2. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
3. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor
4. Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes
5. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat
6. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription
7. Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection
8. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates
9. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism
10. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
11. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus
12. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
13. High-titer packaging cells producing recombinant retroviruses resistant to human serum
14. Identification of a major co-receptor for primary isolates of HIV-1
15. Expression cloning of new receptors used by simian and human immunodeficiency viruses
16. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
17. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
18. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
19. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T
20. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein
21. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells
22. Properties of human foamy virus relevant to its development as a vector for gene therapy
23. Species-specific, postentry barriers to primate immunodeficiency virus infection
24. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
25. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
26. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses
27. Role of the human and murine cyclin T proteins in regulating HIV-1 tat-activation
28. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5
29. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
30. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain
31. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain
32. A block to human immunodeficiency virus type 1 assembly in murine cells
33. Use of retroviral vectors for gene transfer and expression
34. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
35. Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells
36. A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids
37. Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion
38. CD4-independent infection by human immunodeficiency virus type 2 strain ROD/B: The role of the N-terminal domain of CXCR-4 in fusion and entry
39. Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates
40. Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors
41. Evidence for a newly discovered cellular anti-HIV-1 phenotype
42. A transient three-plasmid expression system for the production of high titer retroviral vectors
43. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication
44. Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV-2/B)
45. A human cell factor is essential for HIV-1 Rev action
46. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
47. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b